PharmGen Science, Inc. (KRX:004720)

South Korea · Delayed Price · Currency is KRW

3,765.00

+10.00 (0.27%)

Last updated: Mar 12, 2026, 11:49 AM KST

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Pharmaceuticals	171.29B	166.78B	150.93B	109.87B	96.61B
Pharmaceuticals Growth	2.70%	10.50%	37.38%	13.72%	1.55%
Total	171.29B	166.78B	150.93B	109.87B	96.61B
Total Growth	2.70%	10.50%	37.38%	13.72%	1.55%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
South Korea	170.61B	165.88B	150.06B	109.54B	96.06B
South Korea Growth	2.85%	10.54%	36.99%	14.04%	0.97%
Overseas	677.68M	894.32M	865.92M	322.63M	553.53M
Overseas Growth	-24.22%	3.28%	168.39%	-41.71%	-
Total	171.29B	166.78B	150.93B	109.87B	96.61B
Total Growth	2.70%	10.50%	37.38%	13.72%	1.55%

Source: S&P Global Market Intelligence.